Abstract:Background MicroRNAs (miRNAs) are short, non-coding RNAs (~22 nt) that play important roles in the pathogenesis of human diseases by negatively regulating gene expression. Although miR-196a has been implicated in several other cancers, its role in non-small cell lung cancer (NSCLC) is unknown. The aim of the present study was to examine the expression pattern of miR-196a in NSCLC and its clinical significance, as well as its biological role in tumor progression. Methods Expression of miR-196a was analyzed in 34 NSCLC tissues and five NSCLC cell lines by quantitative reverse-transcription polymerase chain reaction (qRT-PCR). The effect of DNA methylation on miR-196a expression was investigated by 5-aza-2-deoxy-cytidine treatment and bisulfite sequencing. The effect of miR-196a on proliferation was evaluated by MTT and colony formation assays, and cell migration and invasion were evaluated by transwell assays. Analysis of target protein expression was determined by western blotting. Luciferase reporter plasmids were constructed to confirm the action of miR-196a on downstream target genes, including HOXA5 . Differences between the results were tested for significance using Student’s t-test (two-tailed). Results miR-196a was highly expressed both in NSCLC samples and cell lines compared with their corresponding normal counterparts, and the expression of miR-196a may be affected by DNA demethylation. Higher expression of miR-196a in NSCLC tissues was associated with a higher clinical stage, and also correlated with NSCLC lymph-node metastasis. In vitro functional assays demonstrated that modulation of miR-196a expression affected NSCLC cell proliferation, migration and invasion. Our analysis showed that miR-196a suppressed the expression of HOXA5 both at the mRNA and protein levels, and luciferase assays confirmed that miR-196a directly bound to the 3’untranslated region of HOXA5. Knockdown of HOXA5 expression in A549 cells using RNAi was shown to promote NSCLC cell proliferation, migration and invasion. Finally, we observed an inverse correlation between HOXA5 and miR-196a expression in NSCLC tissues. Conclusions Our findings indicate that miR-196a is significantly up-regulated in NSCLC tissues, and regulates NSCLC cell proliferation, migration and invasion, partially via the down-regulation of HOXA5. Thus, miR-196a may represent a potential therapeutic target for NSCLC intervention.

STAT3/miR-135b/NF-κB Axis Confers Aggressiveness and Unfavorable Prognosis in Non-Small-cell Lung Cancer

MiRNA-20a-5p accelerates the proliferation and invasion of non-small cell lung cancer by targeting and downregulating KLF9.

STAT3-induced Long Noncoding RNA LINC00668 Promotes Migration and Invasion of Non-Small Cell Lung Cancer Via the Mir-193A/klf7 Axis.

Down-regulation of MBNL1-AS1 Contributes to Tumorigenesis of NSCLC Via Sponging Mir-135A-5p

The METTL3/miR-196a Axis Predicts Poor Prognosis in Non-small Cell Lung Cancer

MicroRNA‑433 Reduces Cell Proliferation and Invasion in Non‑small Cell Lung Cancer Via Directly Targeting E2F Transcription Factor 3.

Decreased Level Of Mir-1301 Promotes Colorectal Cancer Progression Via Activation Of Stat3 Pathway

MiR-93-5p Up-Regulation is Involved in Non-Small Cell Lung Cancer Cells Proliferation and Migration and Poor Prognosis.

RETRACTED ARTICLE: the Lnc LINC00461/miR-30a-5p Facilitates Progression and Malignancy in Non-Small Cell Lung Cancer Via Regulating ZEB2

MicroRNA-196a Promotes Non-Small Cell Lung Cancer Cell Proliferation and Invasion Through Targeting HOXA5

MiR-21 and MiR-155 Promote Non-Small Cell Lung Cancer Progression by Downregulating SOCS1, SOCS6, and PTEN

Tumor Invasion and Metastasis Regulated by Microrna-184 and Microrna-574-5p in Small-Cell Lung Cancer

Decreased Expression of Mir216a Contributes to Non-Small-Cell Lung Cancer Progression

LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regulating the CAV1/STAT3 pathway

RETRACTED: The Lnc LINC00461/miR-30a-5p facilitates progression and malignancy in non-small cell lung cancer via regulating ZEB2 (Retracted article. See JAN, 2023)

Downregulation of LINC00665 Confers Decreased Cell Proliferation and Invasion Via the Mir-138-5p/e2f3 Signaling Pathway in NSCLC.

MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6

Biology of Human Tumors Decreased Expression of miR 216 a Contributes to Non – Small-Cell Lung Cancer Progression

Down-Regulation of Mir-4500 Promoted Non-Small Cell Lung Cancer Growth

Mir-199A-3p/5p Regulate Tumorgenesis Via Targeting Rheb in Non-Small Cell Lung Cancer

MicroRNA-203 Promotes the Progression of Non-Small Cell Lung Cancer Via Surviving.